DR. KADE Pharmazeutische Fabrik GmbH
Three Questions for Christopher Budde
What was your starting point?
To keep track of its complex value chain, DR. KADE depicts its business model in terms of value drivers and performance targets. The derived financial planning within this driver model is focused on three system applications. The ERP system supplies all the historical data, such as from order processing, materials management, production and financial accounting. From these data, the BI application Qlik Sense and the planning solution Corporate Planner retrieve the values of the Actual dimension.
What are your highlights?
The entire company-wide planning is done in Corporate Planner. While the finance department has full access, the other divisions access the tailor-made planning and report templates in their areas of responsibility via a customized web portal. DR. KADE chose to have CP provided as a cloud service, which doesn't only reduce the workload for its IT department, but also guarantees maximum availability and easy access for all stakeholders from any location and any device.
What lessons have you learned?
As we see it, the following points have turned out to be key success factors in the implementation:
- management of master data in the run-up to implementation
- structuring and harmonization of business processes that are upstream of financial planning and contribute to it
- sufficient internal capacity for the purposes of the implementation
Solutions: Financial Planning, Sales Management
Industry: Manufacturing industry
Sites: Berlin, Germany
Employees: 320
“With the increasing competitive pressure in the pharmaceutical industry, rising personnel and production costs and changes in the
regulatory framework, we need to manage the company’s development in the business model very precisely. We find that the automated forecasting environment for the P&L, balance sheet and cash flow statement from Corporate Planning gives us all the possibilities of driver-based business model analysis and enables management interventions.”
Christopher Budde, Senior Controller
